AR005462A1 - Un proceso para preparar ciertos ciclohexapeptidos y compuestos obtenidos mediante dicho procedimiento. - Google Patents

Un proceso para preparar ciertos ciclohexapeptidos y compuestos obtenidos mediante dicho procedimiento.

Info

Publication number
AR005462A1
AR005462A1 ARP970100139A ARP970100139A AR005462A1 AR 005462 A1 AR005462 A1 AR 005462A1 AR P970100139 A ARP970100139 A AR P970100139A AR P970100139 A ARP970100139 A AR P970100139A AR 005462 A1 AR005462 A1 AR 005462A1
Authority
AR
Argentina
Prior art keywords
alkyl
cyclohexapeptides
procedure
compounds obtained
prepare certain
Prior art date
Application number
ARP970100139A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR005462A1 publication Critical patent/AR005462A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06114—Packages or dispensers for needles or sutures
    • A61B17/06133—Packages or dispensers for needles or sutures of parallelepipedal shape, e.g. made of rectangular or slightly oval panels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06114—Packages or dispensers for needles or sutures
    • A61B2017/06142—Packages or dispensers for needles or sutures having needle- or suture- retaining members, e.g. holding tabs or needle parks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Dentistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un proceso para preparar compuestos aza ciclohexapéptidos de la fórmula (I) en donde R1 es CH2CH2NH2 o CH2CONH2; RI es alquil C9-C21, alquenil C9-C21,alcoxifenil C1-C10, alcoxinaftil C1-C20; o alcoxiterfenil C1-C10;RII es H, alquil C1-C4, alquen ilC3-C4, (CH2)(2-4)OH, o (CH2)(2-4)NRIVRV;RIII es H,alquil C1-C4 alquenil C3-C4OH2, (CH2)(2-4)OH, (CH2)(2-4)NRIVRV; R y tomados junto son (CH2)4, (CH2)5 (CH2)2O(CH2)2 o (CH2)2NH(CH2)2; RIV es H o alquilC1-C4; RV es H o alquil C1-C4; o sales de adición de ácido farmaceuticamente aceptables de ellos que comprende los pasos de: a) reducir el Compuesto II contiofenil para producir un Compuesto IV-a; b) reducir el compuesto IV-a para producir el compuesto IV.
ARP970100139A 1995-02-10 1997-01-14 Un proceso para preparar ciertos ciclohexapeptidos y compuestos obtenidos mediante dicho procedimiento. AR005462A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/386,618 US5552521A (en) 1995-02-10 1995-02-10 Process for preparing certain aza cyclohexapeptides

Publications (1)

Publication Number Publication Date
AR005462A1 true AR005462A1 (es) 1999-06-23

Family

ID=23526350

Family Applications (2)

Application Number Title Priority Date Filing Date
AR33533596A AR001081A1 (es) 1995-02-10 1996-02-07 Un proceso para preparar ciertos aza ciclohexapeptidos y compuestos preparados mediante dicho proceso
ARP970100139A AR005462A1 (es) 1995-02-10 1997-01-14 Un proceso para preparar ciertos ciclohexapeptidos y compuestos obtenidos mediante dicho procedimiento.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR33533596A AR001081A1 (es) 1995-02-10 1996-02-07 Un proceso para preparar ciertos aza ciclohexapeptidos y compuestos preparados mediante dicho proceso

Country Status (21)

Country Link
US (1) US5552521A (es)
EP (1) EP0808330B1 (es)
CN (1) CN1127515C (es)
AR (2) AR001081A1 (es)
AT (1) ATE309266T1 (es)
AU (1) AU692071B2 (es)
BR (1) BR9607721A (es)
CA (1) CA2211314C (es)
CZ (2) CZ286683B6 (es)
DE (1) DE69635405T2 (es)
EA (1) EA000564B1 (es)
ES (1) ES2249778T3 (es)
FI (1) FI120693B (es)
HK (1) HK1004676A1 (es)
HR (1) HRP960054B1 (es)
HU (1) HU229780B1 (es)
NZ (1) NZ302967A (es)
SK (1) SK283115B6 (es)
TW (1) TW515805B (es)
WO (1) WO1996024613A1 (es)
YU (1) YU49459B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0779895T3 (da) * 1994-08-23 2000-03-13 Merck & Co Inc Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
AU692308B2 (en) * 1994-09-16 1998-06-04 Merck Sharp & Dohme Corp. Aza cyclohexapeptide compounds
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
HRP970318B1 (en) * 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
US6069126A (en) * 1996-09-12 2000-05-30 Merck & Co., Inc. Antifungal combination therapy
US5936062A (en) * 1997-06-12 1999-08-10 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
WO2000024694A1 (en) * 1998-10-28 2000-05-04 Eli Lilly And Company Photochemical process for making 1-deoxy-2-keto derivatives
AR035808A1 (es) * 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
US7214768B2 (en) * 2002-04-08 2007-05-08 Merck & Co., Inc. Echinocandin process
EP1785432A1 (en) 2005-11-15 2007-05-16 Sandoz AG Process and intermediates for the synthesis of caspofungin.
SI2049142T2 (sl) 2006-07-26 2016-04-29 Sandoz Ag Formulacije kaspofungina
WO2009002481A1 (en) 2007-06-26 2008-12-31 Merck & Co., Inc. Lyophilized anti-fungal composition
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090291996A1 (en) * 2008-05-21 2009-11-26 Ferenc Korodi Caspofungin free of caspofungin Co
US8048853B2 (en) * 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
WO2010008493A2 (en) * 2008-06-25 2010-01-21 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
US20090324635A1 (en) * 2008-06-25 2009-12-31 Ferenc Korodi Caspofungin free of caspofungin impurity A
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
EP2463293A4 (en) * 2009-08-06 2013-06-05 Shanghai Techwell Biopharm Co AZACYCLOHEXAPEPTIDE BZW. ITS PHARMACEUTICAL ACCEPTABLE SALT, MANUFACTURING PROCESS AND USE
CN101792486A (zh) * 2010-04-12 2010-08-04 浙江海正药业股份有限公司 一种合成醋酸卡泊芬净的方法
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN106397543A (zh) * 2010-09-28 2017-02-15 中化帝斯曼制药有限公司荷兰公司 用于分离环六肽的方法
US8927690B2 (en) * 2010-09-29 2015-01-06 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
CN102367267B (zh) * 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367269B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
CN102367268B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
KR101331984B1 (ko) 2010-12-09 2013-11-25 종근당바이오 주식회사 카스포펀진 제조방법 및 그의 신규 중간체
CN102219833A (zh) * 2011-04-18 2011-10-19 深圳市健元医药科技有限公司 一种更加安全的棘白菌类抗真菌药的制备方法
CN102746384B (zh) * 2011-04-22 2016-01-20 上海天伟生物制药有限公司 一种高纯度的卡泊芬净或其盐及其制备方法和用途
MX2013012161A (es) * 2011-04-28 2014-07-30 Unitris Biopharma Co Ltd Compuesto intermedio de la sintesis de caspofungina y metodo de preparacion de la misma.
CN103483426A (zh) * 2012-06-14 2014-01-01 博瑞生物医药技术(苏州)有限公司 一种氮杂环己肽的制备方法
CA2888625A1 (en) 2012-11-20 2014-05-30 Fresenius Kabi Usa, Llc Caspofungin acetate formulations
EP3620462A1 (en) 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Process for the preparation of caspofungin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
DK0779895T3 (da) * 1994-08-23 2000-03-13 Merck & Co Inc Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
AU692308B2 (en) * 1994-09-16 1998-06-04 Merck Sharp & Dohme Corp. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
AU4914796A (en) 1996-08-27
CA2211314C (en) 2007-04-17
EA199700170A1 (ru) 1997-12-30
CZ252597A3 (cs) 1998-01-14
AR001081A1 (es) 1997-09-24
EP0808330A1 (en) 1997-11-26
CN1127515C (zh) 2003-11-12
SK107997A3 (en) 1998-02-04
SK283115B6 (sk) 2003-02-04
CZ286767B6 (cs) 2000-06-14
ES2249778T3 (es) 2006-04-01
FI973281A0 (fi) 1997-08-08
WO1996024613A1 (en) 1996-08-15
DE69635405D1 (de) 2005-12-15
EA000564B1 (ru) 1999-12-29
HRP960054B1 (en) 2008-07-31
MX9706101A (es) 1997-10-31
TW515805B (en) 2003-01-01
HUP9901085A3 (en) 2000-11-28
FI120693B (fi) 2010-01-29
HRP960054A2 (en) 1997-10-31
HU229780B1 (en) 2014-07-28
CZ286683B6 (en) 2000-06-14
EP0808330B1 (en) 2005-11-09
FI973281A (fi) 1997-08-08
US5552521A (en) 1996-09-03
ATE309266T1 (de) 2005-11-15
BR9607721A (pt) 1998-07-14
HUP9901085A2 (hu) 1999-09-28
YU8496A (sh) 1999-06-15
HK1004676A1 (en) 1998-12-04
AU692071B2 (en) 1998-05-28
DE69635405T2 (de) 2006-07-27
YU49459B (sh) 2006-03-03
CA2211314A1 (en) 1996-08-15
NZ302967A (en) 1998-11-25
CN1173875A (zh) 1998-02-18

Similar Documents

Publication Publication Date Title
AR005462A1 (es) Un proceso para preparar ciertos ciclohexapeptidos y compuestos obtenidos mediante dicho procedimiento.
ES2070175T3 (es) Derivados de acido 4-oxoquinolino-3-carboxilico, su preparacion y su uso.
KR960007545A (ko) 합성 흥분성 아미노산
MY115679A (en) Process for preparing intermediates to florfenicol
ES2183905T3 (es) Inhibidores de metaloproteasa de matriz.
HU9302328D0 (en) Method for producing 5-heteroyl-indole derivatives and one for preparing pharmaceutical preparatives containing them as active substance
IL133627A0 (en) Antithrombotic agents
MY107319A (en) Process for the preparation of cyclic amino acids, as well as intermediates.
NZ331549A (en) Compounds useful in treating sexual dysfunction
ATE245435T1 (de) Totalsynthese des amino hip analogen von didemnin a
AR006058A1 (es) Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido
IL124623A0 (en) Agents for promoting bone formation
IL137891A0 (en) Disinfecting composition
ES2118988T3 (es) Derivados n-sustituidos de n-metil-3-(p-trifluoro-metil-fenoxi)-3-fenil-propil-amina y el procedimiento para su preparacion.
ES2065161T3 (es) Procedimiento y productos intermedios para preparar azabiciclo(2.2.2)octan-3-iminas.
PT93126A (pt) Processo para a preparacao de eteres carboxialquilicos da 2-amino-7- -hidroxitetralina
EA200000924A3 (ru) СПОСОБ ПОЛУЧЕНИЯ ПИРАЗОЛО[4,3-d]ПИРИМИДИН-7-ОН-3-ПИРИДИЛСУЛЬФОНИЛЬНЫХ СОЕДИНЕНИЙ И ИХ ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
ES2110454T3 (es) Compuestos de 6-oxo-azepinoindol, asi como procedimiento y productos intermedios para su preparacion y medicamentos que contienen estos compuestos.
AU4953997A (en) New histidine derivatives, preparation process, and their use as free antiradical agents
TW334428B (en) Novel benzodiazepine derivatives
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
IL116646A0 (en) Antifungal fusacandins
PE25195A1 (es) Sintesis de l-aspartil-d-aminoalcanoil-(s)-o-alquilbencil amida utilizada como endulzante artificial
EA199800287A1 (ru) Производные пептидов
CO5261532A1 (es) Compuestos heterociclicos sililados, procedimiento para la preparacion de estos y composicion farmaceutica que los contiene

Legal Events

Date Code Title Description
FC Refusal